Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes

Giacomo De Luca1, Silvia Laura Bosello1, Francesca Augusta Gabrielli2

  • 1Institute of Rheumatology and Affine Sciences - Department of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.

Plos One
|April 22, 2016
PubMed

Insights

Frequent ventricular ectopic beats (VEBs) detected by 24-hour ECG-Holter monitoring can identify Systemic Sclerosis patients at high risk for sudden cardiac death. This aids in selecting patients who may benefit from implantable cardioverter-defibrillator (ICD) implantation.

Area of Science:

  • Cardiology
  • Rheumatology
  • Medical Diagnostics

Background:

  • Arrhythmias are a significant cause of mortality in Systemic Sclerosis (SSc), contributing to 6% of deaths.
  • Sudden cardiac death (SCD) is a major concern in SSc patients, highlighting the need for improved risk stratification.
  • Identifying prognostic electrocardiogram (ECG) indexes is crucial for preventing adverse cardiac events in SSc.

Purpose of the Study:

  • To evaluate the role of 24-hour ECG-Holter in risk-stratifying SSc patients for life-threatening arrhythmias and SCD.
  • To define specific ECG criteria indicative of poor prognosis in SSc.
  • To determine the utility of Holter monitoring as an adjunct to existing risk assessment tools.

Main Methods:

  • A prospective cohort study involving 100 SSc patients with cardiac symptoms or signs.
  • 24-hour ECG-Holter monitoring was performed on all participants.
  • The primary endpoint was a composite of SCD or the need for implantable cardioverter-defibrillator (ICD) implantation.

Main Results:

  • 56% of patients showed 24-hour ECG-Holter abnormalities, with 24% exhibiting frequent ventricular ectopic beats (VEBs).
  • VEBs correlated with elevated high-sensitive cardiac troponin T (hs-cTnT) and reduced left-ventricular ejection fraction (LV-EF).
  • VEBs exceeding 1190/24h demonstrated 100% sensitivity and 83% specificity for predicting the primary endpoint (AUROC = 0.92).

Conclusions:

  • Frequent VEBs (>1190/24h) on Holter monitoring identify SSc patients at high risk for life-threatening arrhythmias.
  • 24-hour ECG-Holter is a valuable tool for risk-stratifying SSc patients for SCD.
  • ICD implantation may be a life-saving intervention for high-risk SSc patients identified by Holter monitoring.
Abstract

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.5K
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
670
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
783
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
970
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
887
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
738